|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-4-28
|
|
pubmed:abstractText |
Patients undergoing biliopancreatic diversion (BPD) may develop gastric ulcers, particularly within the first postoperative year. The prophylactic use of antisecretory compounds at the usual therapeutic doses, mainly conventional H2-receptor antagonists such as ranitidine, may reduce the incidence of this complication, which occurs in approximately 5% of patients after BPD.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0960-8923
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
36-9
|
|
pubmed:dateRevised |
2007-12-5
|
|
pubmed:meshHeading |
pubmed-meshheading:10065579-Administration, Oral,
pubmed-meshheading:10065579-Adult,
pubmed-meshheading:10065579-Area Under Curve,
pubmed-meshheading:10065579-Biliopancreatic Diversion,
pubmed-meshheading:10065579-Drug Administration Schedule,
pubmed-meshheading:10065579-Female,
pubmed-meshheading:10065579-Follow-Up Studies,
pubmed-meshheading:10065579-Histamine H2 Antagonists,
pubmed-meshheading:10065579-Humans,
pubmed-meshheading:10065579-Male,
pubmed-meshheading:10065579-Middle Aged,
pubmed-meshheading:10065579-Obesity, Morbid,
pubmed-meshheading:10065579-Postoperative Period,
pubmed-meshheading:10065579-Preoperative Care,
pubmed-meshheading:10065579-Ranitidine,
pubmed-meshheading:10065579-Statistics, Nonparametric,
pubmed-meshheading:10065579-Stomach Ulcer,
pubmed-meshheading:10065579-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Orally administered ranitidine plasma concentrations before and after biliopancreatic diversion in morbidly obese patients.
|
|
pubmed:affiliation |
Cattedra di Chirurgia d'Urgenza, Clinica Chirurgica Generale, Università di Sassari, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
